Comparative pharmacokinetics of two tablet formulations of amoxicillin: Bioequivalence assessment

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 4, 2007, Pages 227-231

  Sailer, Reinhard ^a   Arnold, Peter ^a   Erenmemişoǧlu, Aydin ^b   Martin, Wolfgang ^a   Tamur, Uygur ^c   Kanzik, Ilker ^d,e   Hincal, A Atilla ^d,f  

^a Pharmakin GmbH   (Germany)

^b ERCIYES UNIVERSITY   (Turkey)

^c DEVA Holding A   (Turkey)

^d IDE Pharmaceutical Consulting   (Turkey)

^e GAZI UNIVERSITY   (Turkey)

^f HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Amoxicillin, bioequivalence, pharmacokinetics; Antibiotics; CAS 26787 78 0; CAS 61336 70 7; Demoksil

Indexed keywords

AMOXICILLIN; DEMOKSIL; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 34248233576     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296609     Document Type: Article

References (8)

1. Prevot M-H, Jehl F, Rouveix B. Pharmacokinetics of a New Oral Formulation of Amoxicillin. Eur J Drug Metab Pharmacokinet. 1997;22:47-52.
2. Molinaro M, Corona G, Fiorito V, et al. Bioavailability of Two Different Oral Formulations of Amoxicillin in Healthy Subjects. Arzneimittel-Forschung (Drug Research). 1997;47:1406-1410.
3. Todd A, Benfield P. Amoxicilin/Clavulanic Acid: An Update of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use. Drugs. 1990; 39:264-307.
4. Shah V P, Midha K K, Dighe S, et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci. 1992;81:309-312.
5. Note for Guidance on the Investigation of Bioavailability and Bioequivalence Committee for Proprietary Medicinal Products. CPMP/EWP/QWP/1401/98. London;26 July 2001
6. Diletti E, Hauschke D, Steinijans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol. 1992; 30(Suppl 1):51-58.
7. Schulz H-U, Steinijans V W. Striving for standards in bioequivalence assessment. A review. Int J Pharmacol Ther Toxicol. 1991;29:293-298.
8. Gardner S. Bioavailability and bioequivalence requirements. Procedures for establishing a bioequivalence requirement. Fed Reg. 1977;42:1624-1653.